Stroke Trial, Recruiting (NCT05550077)

Stroke Trial, Recruiting NCT05550077 Sponsor: jiaoliqun Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05550077 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had a stroke or a temporary stroke-like episode (called a TIA) that was caused by a narrowed artery inside the brain. A TIA is defined here as a sudden episode of neurological symptoms — such as weakness, difficulty speaking, temporary vision loss in one eye, or needing help walking — that lasted at least 10 minutes but fully resolved within 24 hours.
People whose artery is narrowed by 50% or more, as measured by a specific detailed X-ray imaging test of the blood vessels (called a digital subtraction angiogram).
People where the narrowing is located in at least one of the major arteries inside the brain — specifically the internal carotid artery, vertebral artery, middle cerebral artery, or basilar artery.

Who may not be able to join:

People who have an arteriovenous malformation (an abnormal tangle of blood vessels in the brain) (confirm with trial site).
People who have an aneurysm (a bulge or weak spot in a blood vessel wall) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613911224991

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05550077

Sponsor: jiaoliqun

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +8613911224991

More information: https://clinicaltrials.gov/study/NCT05550077

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had a stroke or a temporary stroke-like episode (called a TIA) that was caused by a narrowed artery inside the brain. A TIA is defined here as a sudden episode of neurological symptoms — such as weakness, difficulty speaking, temporary vision loss in one eye, or needing help walking — that lasted at least 10 minutes but fully resolved within 24 hours.
People whose artery is narrowed by 50% or more, as measured by a specific detailed X-ray imaging test of the blood vessels (called a digital subtraction angiogram).
People where the narrowing is located in at least one of the major arteries inside the brain — specifically the internal carotid artery, vertebral artery, middle cerebral artery, or basilar artery.

Who may not be able to join:

People who have an arteriovenous malformation (an abnormal tangle of blood vessels in the brain) (confirm with trial site).
People who have an aneurysm (a bulge or weak spot in a blood vessel wall) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

jiaoliqun

Registry

ClinicalTrials.gov

Start date

15 March 2020

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Safety outcomes: short-term death or stroke

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov